Duration of untreated illness and depression severity are associated with cognitive impairment in mood disorders

References

• Altamura AC, Dell’Osso B, D’Urso N, Russo M, Fumagalli S, Mundo E. 2008. Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder. CNS Spectr. 13(5):415–422. doi:10.1017/S1092852900016588
   PubMed Web of Science ®Google Scholar
• Altamura AC, Dell’Osso B, Mundo E, Dell’Osso L. 2007. Duration of untreated illness in major depressive disorder: a naturalistic study. Inter J Clin Pract. 61(10):1697–1700. doi:10.1111/j.1742-1241.2007.01450.x
   PubMed Web of Science ®Google Scholar
• Altamura AC, Dell’Osso B, Vismara S, Mundo E. 2008. May duration of untreated illness influence the long-term course of major depressive disorder? Eur Psychiatr. 23(2):92–96. doi:10.1016/j.eurpsy.2007.11.004
   PubMed Web of Science ®Google Scholar
• Balanzá-Martínez V, Tabarés-Seisdedos R, Selva-Vera G, Martínez-Arán A, Torrent C, Salazar-Fraile J, Leal-Cercós C, Vieta E, Gómez-Beneyto M. 2005. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom. 74(2):113–119. doi:10.1159/000083170
   PubMed Web of Science ®Google Scholar
• Baune BT, Renger L. 2014. Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review. Psychiatry Res. 219(1):25–50. doi:10.1016/j.psychres.2014.05.013
   PubMed Web of Science ®Google Scholar
• Bearden CE, Glahn DC, Monkul ES, Barrett J, Najt P, Villarreal V, Soares JC. 2006. Patterns of memory impairment in bipolar disorder and unipolar major depression. Psychiatry Res. 142(2-3):139–150. doi:10.1016/j.psychres.2005.08.010
   PubMed Web of Science ®Google Scholar
• Bo Q, Dong F, Li X, Li F, Li P, Yu H, He F, Zhang G, Wang Z, Ma X. 2019. Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls. Psychiatry Clin Neurosci. 73(2):70–76. doi:10.1111/pcn.12797
   PubMed Web of Science ®Google Scholar
• Buoli M, Dell’Osso B, Zaytseva Y, Gurovich IY, Movina L, Dorodnova A, Shmuckler A, Altamura AC. 2013. Duration of untreated illness (DUI) and schizophrenia sub-types: a collaborative study between the universities of Milan and Moscow. Int J Soc Psychiatry. 59(8):765–770. doi:10.1177/0020764012456807
   PubMed Web of Science ®Google Scholar
• Burdick KE, Ketter TA, Goldberg JF, Calabrese JR. 2015. Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry. 76(03):e342–50. doi:10.4088/JCP.14cs09399
   PubMedGoogle Scholar
• Daniel BD, Montali A, Gerra ML, Innamorati M, Girardi P, Pompili M, Amore M. 2013. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission. J Psychiatric Pract. 19(4):275–287. doi:10.1097/01.pra.0000432597.79019.e2
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Buoli M, Hollander E, Altamura AC. 2010. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. World J Biol Psychiatry11(1):59–65. doi:10.3109/15622970903418544
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Camuri G, Benatti B, Buoli M, Altamura AC. 2013. Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder. Early Intervention Psychiatry. 7(4):374–380. doi:10.1111/eip.12016
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Cinnante C, Di Giorgio A, Cremaschi L, Palazzo MC, Cristoffanini M, Fazio L, Dobrea C, Avignone S, Triulzi F. 2015. Altered prefrontal cortex activity during working memory task in Bipolar Disorder: a functional Magnetic Resonance Imaging study in euthymic bipolar I and II patients. J Affective Disorders. 184:116–122. doi:10.1016/j.jad.2015.05.026
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Oldani L, Camuri G, Benatti B, Grancini B, Arici C, Cremaschi L, Palazzo M, Spagnolin G, Dobrea C. 2016. Reduced duration of untreated illness over time in patients with schizophrenia spectrum, mood and anxiety disorders. Psychiatry Clin Neurosci. 70(5):202–210. doi:10.1111/pcn.12380
   PubMed Web of Science ®Google Scholar
• Depp CA, Savla GN, Moore DJ, Palmer BW, Stricker JL, Lebowitz BD, Jeste DV. 2008. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disorders. 10(6):684–690. doi:10.1111/j.1399-5618.2008.00601.x
   PubMed Web of Science ®Google Scholar
• Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. 2003. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry. 64(1):86–93. doi:10.4088/JCP.v64n0116
   PubMed Web of Science ®Google Scholar
• Douglas KM, Gallagher P, Robinson LJ, Carter JD, McIntosh VV, Frampton CM, Watson S, Young AH, Ferrier IN, Porter RJ. 2018. Prevalence of cognitive impairment in major depression and bipolar disorder. Bipolar Disord. 20(3):260–274. doi:10.1111/bdi.12602
   PubMed Web of Science ®Google Scholar
• Duffy A. 2000. Toward effective early intervention and prevention strategies for major affective disorders: a review of antecedents and risk factors. Can J Psychiatry. 45(4):340–348. doi:10.1177/070674370004500402
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. 1975. Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 12(3):189–198. doi:10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. 2017. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), Part 3: the clinical guidelines. Int J Neuropsychopharmacol. 20(2):180–195. doi:10.1093/ijnp/pyw109
   PubMed Web of Science ®Google Scholar
• Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. 2005. The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 58(11):859–864. doi:10.1016/j.biopsych.2005.04.056
   PubMed Web of Science ®Google Scholar
• Freitas S, Simoes MR, Alves L, Duro D, Santana I. 2012. Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia. J Geriatr Psychiatry Neurol. 25(3):146–154. doi:10.1177/0891988712455235
   PubMed Web of Science ®Google Scholar
• Freitas S, Simoes MR, Alves L, Vicente M, Santana I. 2012. Montreal Cognitive Assessment (MoCA): validation study for vascular dementia. J Int Neuropsychol Soc. 18(6):1031–1040. doi:10.1017/S135561771200077X
   PubMed Web of Science ®Google Scholar
• Galimberti C, Caricasole V, Bosi MF, Viganò CA, Ketter TA, Dell’Osso B. 2019. Clinical features and patterns of psychopharmacological prescription in bipolar patients with vs without anxiety disorders at onset. Early Intervention Psychiatry. 1–9. doi:10.1111/eip.12900
   PubMed Web of Science ®Google Scholar
• Gildengers AG, Butters MA, Chisholm D, Anderson SJ, Begley A, Holm M, Rogers JC, Reynolds CF, Mulsant BH. 2012. Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disorders. 14(2):198–205. doi:10.1111/j.1399-5618.2012.00995.x
   PubMed Web of Science ®Google Scholar
• Glahn DC, Bearden CE, Barguil M, Barrett J, Reichenberg A, Bowden CL, Soares JC, Velligan DI. 2007. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry. 62(8):910–916. doi:10.1016/j.biopsych.2007.02.001
   PubMed Web of Science ®Google Scholar
• Goldberg JF, Ernst CL. 2002. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 63(11):985–991. doi:10.4088/JCP.v63n1105
   PubMed Web of Science ®Google Scholar
• Gorwood P, Corruble E, Falissard B, Goodwin GM. 2008. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. AJP. 165(6):731–739. doi:10.1176/appi.ajp.2008.07040574
   Google Scholar
• Gualtieri CT, Morgan DW. 2008. The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry. 69(7):1122–1130. doi:10.4088/JCP.v69n0712
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23(1):56–62. Retrieved from http://jnnp.bmj.com/content/23/1/56.abstract. doi:10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. British Journal of Medical Psychology. 32(1):50–55. doi:10.1111/j.2044-8341.1959.tb00467.x
   PubMed Web of Science ®Google Scholar
• Hermens DF, Naismith SL, Redoblado Hodge MA, Scott EM, Hickie IB. 2010. Impaired verbal memory in young adults with unipolar and bipolar depression. Early Intervention in Psychiatry. 4(3):227–233. doi:10.1111/j.1751-7893.2010.00194.x
   PubMed Web of Science ®Google Scholar
• Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Abarca JE, Herrera-Guzmán D, Montelongo-Pedraza P, Padrós Blázquez F, Peró-Cebollero M, Guàrdia-Olmos J. 2010. Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. Journal of Affective Disorders. 123(1-3):341–350. doi:10.1016/j.jad.2009.10.009
   PubMed Web of Science ®Google Scholar
• Herrmann LL, Le Masurier M, Ebmeier KP. 2007. White matter hyperintensities in late life depression: a systematic review. Journal of Neurology, Neurosurgery, and Psychiatry. 79(6):619–624. doi:10.1136/jnnp.2007.124651
   PubMed Web of Science ®Google Scholar
• Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. 2009. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 73(21):1738–1745. doi:10.1212/WNL.0b013e3181c34b47
   PubMed Web of Science ®Google Scholar
• Lee RSC, Hermens DF, Porter MA, Redoblado-Hodge MA. 2012. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affective Disorders. 140(2):113–124. doi:10.1016/j.jad.2011.10.023
   PubMed Web of Science ®Google Scholar
• Lemos-Miller A, Kearney CA. 2006. Depression and ethnicity as intermediary variables among dissociation, trauma-related cognitions, and PTSD symptomatology in youths. J Nerv Ment Dis. 194(8):584–590. doi:10.1097/01.nmd.0000230407.12687.ba
   PubMed Web of Science ®Google Scholar
• Liu I-C, Chiu C-H, Yang T-T. 2010. The effects of gender and a co-occurring depressive disorder on neurocognitive functioning in patients with alcohol dependence. Alcohol Alcohol. 45(3):231–236. doi:10.1093/alcalc/agq016
   PubMed Web of Science ®Google Scholar
• Mak ADP, Lau DTY, Chan AKW, So SHW, Leung O, Wong SLY, Lam L, Leung CM, Lee S. 2018. Cognitive impairment in treatment-Naive Bipolar II and Unipolar depression. Sci Rep. 8(1):1905. doi:10.1038/s41598-018-20295-3
   PubMedGoogle Scholar
• Martinez-Aran A, Torrent C, Tabares-Seisdedos R, Salamero M, Daban C, Balanza-Martinez V, Sanchez-Moreno J, Goikolea JM, Benabarre A, Colom F. 2008. Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry. 69(2):233–239. doi:10.4088/JCP.v69n0209
   PubMed Web of Science ®Google Scholar
• McDermott LM, Ebmeier KP. 2009. A meta-analysis of depression severity and cognitive function. J Affective Disorders. 119(1-3):1–8. doi:10.1016/j.jad.2009.04.022
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M, Baskaran A. 2013. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 30(6):515–527. doi:10.1002/da.22063
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CWY, Miranda A, Fulgosi D, Kennedy SH. 2007. Should depressive syndromes be reclassified as “Metabolic Syndrome Type II. ? Ann Clinical Psychiatry 19(4):257–264. doi:10.1080/10401230701653377
   PubMedGoogle Scholar
• Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, López-Jaramillo C, Sumiyoshi T. 2017. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 19(8):614–626. doi:10.1111/bdi.12534
   PubMed Web of Science ®Google Scholar
• Mitchell AJ. 2009. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatric Res. 43(4):411–431. doi:10.1016/j.jpsychires.2008.04.014
   PubMed Web of Science ®Google Scholar
• Moirand R, Galvao F, Lecompte M, Poulet E, Haesebaert F, Brunelin J. 2018. Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy. Psychiatry Res. 259(August 2017):476–481. doi:10.1016/j.psychres.2017.11.022
   PubMedGoogle Scholar
• Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. 2008. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients. J Clin Psychiatry. 69(5):712–719. doi:10.4088/JCP.v69n0504
   PubMed Web of Science ®Google Scholar
• Musso MW, Cohen AS, Auster TL, McGovern JE. 2014. Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness. Psychiatry Research. 220(1-2):664–668. doi:10.1016/j.psychres.2014.07.078
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bã©Dirian Vér, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. 2005. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J American Geriatrics Soc. 53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, et al. 2013. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. AJP. 170(11):1249–1262. doi:10.1176/appi.ajp.2013.13020185.
   Google Scholar
• Riso LP, Miyatake RK, Thase ME. 2002. The search for determinants of chronic depression: a review of six factors. J Affective Disorders. 70(2):103–115. doi:10.1016/S0165-0327(01)00376-7
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Kakar R, McIntyre RS. 2016. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. IJNPPY. 19(2):pyv082–13. doi:10.1093/ijnp/pyv082
   Google Scholar
• Russo M, Mahon K, Burdick KE. 2015. Measuring cognitive function in MDD: emerging assessment tools. Depress Anxiety. 32(4):262–269. doi:10.1002/da.22297
   PubMed Web of Science ®Google Scholar
• Samamé C, Szmulewicz AG, Valerio MP, Martino DJ, Strejilevich SA. 2017. Are major depression and bipolar disorder neuropsychologically distinct?. Eur Psychiatr. 39:17–26. doi:10.1016/j.eurpsy.2016.06.002
   PubMed Web of Science ®Google Scholar
• Semkovska M, Quinlivan L, O’Grady T, Johnson R, Collins A, O’Connor J, Knittle H, Ahern E, Gload T. 2019. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 6(10):851–861. doi:10.1016/S2215-0366(19)30291-3
   PubMed Web of Science ®Google Scholar
• Senturk Cankorur V, Demirel H, Atbasoglu C. 2017. Cognitive Functioning in Euthymic Bipolar Patients on Monotherapy with Novel Antipsychotics or Mood Stabilizers. Arch Neuropsychiatr. 54(3):244–250. doi:10.5152/npa.2017.15883
   Google Scholar
• Smith T, Gildeh N, Holmes C. 2007. The montreal cognitive assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 52(5):329–332. doi:10.1177/070674370705200508
   PubMed Web of Science ®Google Scholar
• Sweeney JA, Kmiec JA, Kupfer DJ. 2000. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry. 48(7):674–684. doi:10.1016/S0006-3223(00)00910-0
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Greer TL. 2014. Cognitive dysfunction in unipolar depression: implications for treatment. J Affective Disorders. 152-154:19–27. doi:10.1016/j.jad.2013.09.012
   PubMed Web of Science ®Google Scholar
• Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, Ma J, Chen J. 2012. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. Journal of Affective Disorders. 136(3):328–339. doi:10.1016/j.jad.2011.11.029
   PubMed Web of Science ®Google Scholar
• Yang Z, Abdul Rashid NA, Quek YF, Lam M, See YM, Maniam Y, Dauwels J, Tan BL, Lee J. 2018. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophrenia Research. 199:58–63. doi:10.1016/j.schres.2018.03.008
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S. 2018. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 20(2):97–170. doi:10.1111/bdi.12609
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 133(5):429–435. doi:10.1192/bjp.133.5.429
   PubMed Web of Science ®Google Scholar